Physician profile
Michelle Tran
NPI 1225552599
$2,455.86
in general payments reported to CMS, 2019-2025
17 companies · $309 in 2025
The $309 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $370 · 2020: $172 · 2021: $234 · 2022: $411 · 2023: $465 · 2024: $496 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,269.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $609.62 | 2019-2025 | Precision7, Precision 1, Precision 7 |
| Bausch & Lomb Americas INC. | $410.95 | 2022-2025 | Infuse, Xiidra |
| Tarsus Pharmaceuticals, INC. | $256.05 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $234.90 | 2019-2021 | |
| Coopervision INC. | $215.90 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Johnson & Johnson Vision Care, INC. | $201.88 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $94.22 | 2019 | |
| Oyster Point Pharma, INC. | $87.09 | 2022-2024 | Tyrvaya |
| Abb Con-Cise Optical Group LLC | $75.65 | 2021-2024 | Contact Lens, Spectacle Lenses |
| Dompe US, INC. | $66.14 | 2025 | Oxervate |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Shire North American Group INC | $36.93 | 2019 | |
| Oasis Medical, INC. | $36.00 | 2020-2022 | |
| Allergan, INC. | $30.00 | 2020 | |
| Sight Sciences, INC. | $25.51 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $21.35 | 2021 | |
| Abbvie INC. | $14.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.